Mouse CEA(Carcinoembryonic Antigen) ELISA Kit
To Order Contact Us: [email protected]
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| RDR-CEA-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 438 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| RDR-CEA-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 600 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| RD-CEA-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 420 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| RD-CEA-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 574.8 |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| 20-abx153807 | Abbexa |
|
|
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| abx053218-96tests | Abbexa | 96 tests | EUR 801.6 |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| abx255256-96tests | Abbexa | 96 tests | EUR 801.6 |
Mouse Carcinoembryonic Antigen(CEA)ELISA Kit |
|||
| QY-E20269 | Qayee Biotechnology | 96T | EUR 433.2 |
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| SEA150Mu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 4138.42 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| SEA150Mu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | EUR 445.99 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| SEA150Mu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | EUR 585.7 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| SEA150Mu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | EUR 2275.63 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Mouse Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Mouse Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| 4-SEA150Mu | Cloud-Clone |
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Mouse Carcinoembryonic Antigen (CEA) in samples from Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids with no significant corss-reactivity with analogues from other species. |
|||
Mouse Carcinoembryonic Antigen ELISA Kit (CEA) |
|||
| RK02678 | Abclonal | 96 Tests | EUR 625.2 |
Carcinoembryonic Antigen (CEA) (Mouse) ELISA Kit |
|||
| E4741-100 | Biovision | each | EUR 966 |
Carcinoembryonic Antigen (CEA) |
|||
| MO47049 | Neuromics | 0.5 ml | EUR 418.8 |
Carcinoembryonic Antigen (CEA) |
|||
| HY-P0277 | MedChemExpress | 5mg | EUR 1678.8 |
ELISA kit for Mouse CEA (Carcinoembryonic Antigen) |
|||
| E-EL-M0232 | Elabscience Biotech | 1 plate of 96 wells | EUR 640.8 |
|
Description: A sandwich ELISA kit for quantitative measurement of Mouse CEA (Carcinoembryonic Antigen) in samples from Serum, Plasma, Cell supernatant |
|||
ELISA kit for Mouse CEA (Carcinoembryonic Antigen) |
|||
| ELK1130 | ELK Biotech | 1 plate of 96 wells | EUR 446.4 |
|
Description: A sandwich ELISA kit for detection of Carcinoembryonic Antigen from Mouse in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
Mouse Carcinoembryonic Antigen (CEA) CLIA Kit |
|||
| 20-abx491146 | Abbexa |
|
|
Mouse Carcinoembryonic Antigen (CEA) Protein |
|||
| 20-abx065720 | Abbexa |
|
|
Mouse Carcinoembryonic Antigen (CEA) Protein |
|||
| 20-abx065722 | Abbexa |
|
|
Human carcinoembryonic antigen, CEA ELISA Kit |
|||
| CSB-E04767h-24T | Cusabio | 1 plate of 24 wells | EUR 198 |
|
Description: Quantitative sandwich ELISA kit for measuring Human carcinoembryonic antigen, CEA in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Human carcinoembryonic antigen, CEA ELISA Kit |
|||
| 1-CSB-E04767h | Cusabio |
|
|
|
Description: Quantitative sandwich ELISA kit for measuring Human carcinoembryonic antigen, CEA in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| 20-abx155329 | Abbexa |
|
|
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| 20-abx151022 | Abbexa |
|
|
Chicken Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| abx356418-96tests | Abbexa | 96 tests | EUR 990 |
Rabbit Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| abx362811-96tests | Abbexa | 96 tests | EUR 990 |
Sheep Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| abx364185-96tests | Abbexa | 96 tests | EUR 1111.2 |
Monkey Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| abx359529-96tests | Abbexa | 96 tests | EUR 990 |
Pig Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| abx361295-96tests | Abbexa | 96 tests | EUR 990 |
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| abx256792-96tests | Abbexa | 96 tests | EUR 801.6 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| abx250227-96tests | Abbexa | 96 tests | EUR 764.4 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| LF-EK60048 | Abfrontier | 1Ćā96T | EUR 814.8 |
Human CEA(Carcinoembryonic Antigen) ELISA Kit |
|||
| EH0090 | FN Test | 96T | EUR 628.92 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.188 ng/ml |
|||
Carcinoembryonic Antigen (CEA) (human) ELISA Kit |
|||
| K4805-100 | Biovision | 100 assays | EUR 970.8 |
|
Description: Sensitive, Colorimetric Assay |
|||
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| PRB-5059 | Cell Biolabs | 96 assays | EUR 686.4 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| PRB-5059-5 | Cell Biolabs | 5 x 96 assays | EUR 2739.6 |
Rat Carcinoembryonic Antigen(CEA)ELISA Kit |
|||
| QY-E10372 | Qayee Biotechnology | 96T | EUR 433.2 |
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| SEA150Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 3470.83 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| SEA150Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | EUR 391.01 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| SEA150Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | EUR 507.16 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| SEA150Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | EUR 1922.21 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids. |
|||
Human Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| 4-SEA150Hu | Cloud-Clone |
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Carcinoembryonic Antigen (CEA) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids with no significant corss-reactivity with analogues from other species. |
|||
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| SEA150Ra-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 4358.33 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids. |
|||
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| SEA150Ra-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | EUR 464.1 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids. |
|||
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| SEA150Ra-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | EUR 611.57 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids. |
|||
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| SEA150Ra-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | EUR 2392.06 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Rat Carcinoembryonic Antigen (CEA) in serum, plasma, tissue homogenates and other biological fluids. |
|||
Rat Carcinoembryonic Antigen (CEA) ELISA Kit |
|||
| 4-SEA150Ra | Cloud-Clone |
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Rat Carcinoembryonic Antigen (CEA) in samples from Serum, plasma, tissue homogenates and other biological fluids with no significant corss-reactivity with analogues from other species. |
|||
Human Carcinoembryonic Antigen ELISA Kit (CEA) |
|||
| RK01085 | Abclonal | 96 Tests | EUR 625.2 |
Rat Carcinoembryonic Antigen ELISA Kit (CEA) |
|||
| RK03562 | Abclonal | 96 Tests | EUR 625.2 |
Carcinoembryonic Antigen (CEA) (Human) ELISA Kit |
|||
| E4740-100 | Biovision | each | EUR 966 |
Carcinoembryonic Antigen (CEA) (Rat) ELISA Kit |
|||
| E4742-100 | Biovision | each | EUR 836.4 |
Canine Carcinoembryonic Antigen(CEA)ELISA Kit |
|||
| YLA0016CA-48T | Shanghai YL Biotech | 48T | EUR 502.5 |
Canine Carcinoembryonic Antigen(CEA)ELISA Kit |
|||
| YLA0016CA-96T | Shanghai YL Biotech | 96T | EUR 618.75 |
Human carcinoembryonic antigen (CEA) antigen |
|||
| CEA15-N-100 | Alpha Diagnostics | 100 ug | EUR 270 |
Human Carcinoembryonic Antigen (CEA) ELISA |
|||
| LF-EK0161 | Abfrontier | 1Ćā96T | EUR 723.6 |
Eukaryotic Carcinoembryonic Antigen (CEA) |
|||
| 4-EPA150Hu61 | Cloud-Clone |
|
|
|
Description: Recombinant Human Carcinoembryonic Antigen expressed in: 293F cell |
|||
Carcinoembryonic Antigen (CEA) Antibody |
|||
| 20-abx102321 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
| 20-abx102322 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
| 20-abx102323 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
| 20-abx102324 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
| 20-abx171571 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
| 20-abx171572 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
| 20-abx175703 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
| abx120020-1mg | Abbexa | 1 mg | EUR 944.4 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
| 20-abx128498 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
| 20-abx128499 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
| abx020536-1mg | Abbexa | 1 mg | EUR 944.4 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
| abx020540-1mg | Abbexa | 1 mg | EUR 944.4 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
| abx020541-1mg | Abbexa | 1 mg | EUR 910.8 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
| abx020542-1mg | Abbexa | 1 mg | EUR 828 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
| abx020543-1mg | Abbexa | 1 mg | EUR 886.8 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
| abx020544-1mg | Abbexa | 1 mg | EUR 828 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
| abx020545-1mg | Abbexa | 1 mg | EUR 828 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
| abx020546-1mg | Abbexa | 1 mg | EUR 828 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
| abx022526-01ml | Abbexa | 0.1 ml | EUR 1328.4 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
| abx231576-100ug | Abbexa | 100 ug | EUR 577.2 |
Carcinoembryonic Antigen (CEA) Antibody |
|||
| 20-abx270133 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
| 20-abx270165 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody |
|||
| 20-abx270190 | Abbexa |
|
|
Active Carcinoembryonic Antigen (CEA) |
|||
| 4-APA150Hu04 | Cloud-Clone |
|
|
|
Description: Recombinant Human Carcinoembryonic Antigen expressed in: Available from E.coli, Yeast, Baculovirus and Mammalian cells |
|||
Recombinant Carcinoembryonic Antigen (CEA) |
|||
| 4-RPA150Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human Carcinoembryonic Antigen expressed in: E.coli |
|||
Recombinant Carcinoembryonic Antigen (CEA) |
|||
| 4-RPA150Hu02 | Cloud-Clone |
|
|
|
Description: Recombinant Human Carcinoembryonic Antigen expressed in: E.coli |
|||
Recombinant Carcinoembryonic Antigen (CEA) |
|||
| 4-RPA150Hu03 | Cloud-Clone |
|
|
|
Description: Recombinant Human Carcinoembryonic Antigen expressed in: E.coli |
|||
Recombinant Carcinoembryonic Antigen (CEA) |
|||
| 4-RPA150Hu04 | Cloud-Clone |
|
|
|
Description: Recombinant Human Carcinoembryonic Antigen expressed in: E.coli |
|||
Recombinant Carcinoembryonic Antigen (CEA) |
|||
| 4-RPA150Mu01 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Carcinoembryonic Antigen expressed in: E.coli |
|||
Recombinant Carcinoembryonic Antigen (CEA) |
|||
| 4-RPA150Mu02 | Cloud-Clone |
|
|
|
Description: Recombinant Mouse Carcinoembryonic Antigen expressed in: E.coli |
|||
Recombinant Carcinoembryonic Antigen (CEA) |
|||
| 4-RPA150Ra01 | Cloud-Clone |
|
|
|
Description: Recombinant Rat Carcinoembryonic Antigen expressed in: E.coli |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| RQ5159 | NSJ Bioreagents | 100ul | EUR 419 |
CEA Antibody / Carcinoembryonic Antigen |
|||
| V8370-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Carcinoembryonic antigen (CEA) is a glycoprotein produced in colorectal cancer tissues. In normal adult tissue, CEA is expressed in the apical border and, to a lesser extent in the cytoplasm, of the columnar cells of colon, small intestine, stomach (surface epithelium, mucous neck cells and weakly in pyloric mucous cells), pancreatic ducts, secretory epithelia of sweat glands, squamous epithelial cells of the tongue, esophagus,uterine cervix, and urothelium. The CEA antibody is a useful aid for classification of adenocarcinomas, notably in the gastrointestinal tract, including colonic and pancreatic carcinomas. IHC results also aid in the classification of secretory meningiomas and medullary carcinoma of the thyroid. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V8370-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: Carcinoembryonic antigen (CEA) is a glycoprotein produced in colorectal cancer tissues. In normal adult tissue, CEA is expressed in the apical border and, to a lesser extent in the cytoplasm, of the columnar cells of colon, small intestine, stomach (surface epithelium, mucous neck cells and weakly in pyloric mucous cells), pancreatic ducts, secretory epithelia of sweat glands, squamous epithelial cells of the tongue, esophagus,uterine cervix, and urothelium. The CEA antibody is a useful aid for classification of adenocarcinomas, notably in the gastrointestinal tract, including colonic and pancreatic carcinomas. IHC results also aid in the classification of secretory meningiomas and medullary carcinoma of the thyroid. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V8370SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Carcinoembryonic antigen (CEA) is a glycoprotein produced in colorectal cancer tissues. In normal adult tissue, CEA is expressed in the apical border and, to a lesser extent in the cytoplasm, of the columnar cells of colon, small intestine, stomach (surface epithelium, mucous neck cells and weakly in pyloric mucous cells), pancreatic ducts, secretory epithelia of sweat glands, squamous epithelial cells of the tongue, esophagus,uterine cervix, and urothelium. The CEA antibody is a useful aid for classification of adenocarcinomas, notably in the gastrointestinal tract, including colonic and pancreatic carcinomas. IHC results also aid in the classification of secretory meningiomas and medullary carcinoma of the thyroid. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2087-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: The COL-1 antibody recognizes proteins of 80-200kDa, identified as different members of the Carcinoembryonic Antigen family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. CEA antibody is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are positive) from pleural mesotheliomas (rarely or weakly positive). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2087-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: The COL-1 antibody recognizes proteins of 80-200kDa, identified as different members of the Carcinoembryonic Antigen family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. CEA antibody is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are positive) from pleural mesotheliomas (rarely or weakly positive). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2087IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: The COL-1 antibody recognizes proteins of 80-200kDa, identified as different members of the Carcinoembryonic Antigen family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. CEA antibody is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are positive) from pleural mesotheliomas (rarely or weakly positive). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2087SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: The COL-1 antibody recognizes proteins of 80-200kDa, identified as different members of the Carcinoembryonic Antigen family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. CEA antibody is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are positive) from pleural mesotheliomas (rarely or weakly positive). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2088-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2088-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2088IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2088SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2089-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2089-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2089IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2089SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2375-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2375-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2375IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2375SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2376-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2376-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2376CF488-100T | NSJ Bioreagents | 100 Tests | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2376IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2376SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V3716-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V3716-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V3716IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V3716SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V7069-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V7069-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V7069IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V7069SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2444-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2444-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2444IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2444SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2445-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2445-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2445SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2446-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leukocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2446-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leukocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2446IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leukocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2446SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA) and shows a cross-reaction with human polymorphonuclear leukocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2447-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2447-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2447IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V2447SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V3527-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V3527-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V3527SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb reacts with nonspecific cross-reacting antigen (NCA). It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V3597-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V3597-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V3597IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V3597SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200 kDa, identified as different members of the CEA (Carcinoembryonic Antigen) family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This antibody does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. The antibody shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). CEA antibody positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V3598-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V3598-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V3598IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V3598SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion. CEA is normally produced in gastrointestinal tissue during fetal development, but the production stops before birth. Therefore, CEA is usually present only at very low levels in the blood of healthy adults. However, the serum levels are raised in some types of cancer, which means that it can be used as a tumor marker in clinical tests. [Wiki] |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V3599-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki] |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V3599-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki] |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V3599IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki] |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V3599SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: CEA are glycosyl phosphatidyl inositol (GPI) cell-surface-anchored glycoproteins whose specialized sialofucosylated glycoforms serve as functional colon carcinoma L-selectin and E-selectin ligands, which may be critical to the metastatic dissemination of colon carcinoma cells. Immunologically they are characterized as members of the CD66 cluster of differentiation. [Wiki] |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V8631-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: The CD66 (carcinoembryonic antigen, CEA, biliary glycoprotein I, BGP-1, CEACAM) immunoglobulin superfamily of genes encode cell adhesion proteins, which are expressed at higher levels in tumorous tissues than in normal tissues. The human CD66 gene family is a diverse set of glycoproteins of epithelial and hematopoietic lineage that comprises 29 genes, which map to chromosome position 19q13.2. CD66A, CD66B, CD66C, CD66D, CD66E and CD66F are the best characterized CD66 antigens, and CD66A-D expression upregulates on the surface of granulocytes upon stimulation. Certain CD66 family members mediate homotypic and heterotypic intercellular adhesion events. CD66E, also known as CEA, is a well known tumor marker and a heavily glycosylated GPI-linked cell surface molecule. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V8631-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: The CD66 (carcinoembryonic antigen, CEA, biliary glycoprotein I, BGP-1, CEACAM) immunoglobulin superfamily of genes encode cell adhesion proteins, which are expressed at higher levels in tumorous tissues than in normal tissues. The human CD66 gene family is a diverse set of glycoproteins of epithelial and hematopoietic lineage that comprises 29 genes, which map to chromosome position 19q13.2. CD66A, CD66B, CD66C, CD66D, CD66E and CD66F are the best characterized CD66 antigens, and CD66A-D expression upregulates on the surface of granulocytes upon stimulation. Certain CD66 family members mediate homotypic and heterotypic intercellular adhesion events. CD66E, also known as CEA, is a well known tumor marker and a heavily glycosylated GPI-linked cell surface molecule. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V8631SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: The CD66 (carcinoembryonic antigen, CEA, biliary glycoprotein I, BGP-1, CEACAM) immunoglobulin superfamily of genes encode cell adhesion proteins, which are expressed at higher levels in tumorous tissues than in normal tissues. The human CD66 gene family is a diverse set of glycoproteins of epithelial and hematopoietic lineage that comprises 29 genes, which map to chromosome position 19q13.2. CD66A, CD66B, CD66C, CD66D, CD66E and CD66F are the best characterized CD66 antigens, and CD66A-D expression upregulates on the surface of granulocytes upon stimulation. Certain CD66 family members mediate homotypic and heterotypic intercellular adhesion events. CD66E, also known as CEA, is a well known tumor marker and a heavily glycosylated GPI-linked cell surface molecule. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V8890-100UG | NSJ Bioreagents | 100ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V8890-20UG | NSJ Bioreagents | 20ug | EUR 219 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V8890SAF-100UG | NSJ Bioreagents | 100ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V9002-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V9002-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V9002IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V9002SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V9003-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V9003-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V9003IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V9003SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V9008-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V9008-20UG | NSJ Bioreagents | 20 ug | EUR 219 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V9008IHC-7ML | NSJ Bioreagents | 7 ml | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V9008SAF-100UG | NSJ Bioreagents | 100 ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This mAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V9164-100UG | NSJ Bioreagents | 100ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V9164-20UG | NSJ Bioreagents | 20ug | EUR 219 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V9164SAF-100UG | NSJ Bioreagents | 100ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V9318-100UG | NSJ Bioreagents | 100ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V9318-20UG | NSJ Bioreagents | 20ug | EUR 219 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V9318SAF-100UG | NSJ Bioreagents | 100ug | EUR 499 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V4046-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V4046-20UG | NSJ Bioreagents | 20 ug | EUR 153.3 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
CEA Antibody / Carcinoembryonic Antigen |
|||
| V4046SAF-100UG | NSJ Bioreagents | 100 ug | EUR 349.3 |
|
Description: This antibody recognizes proteins of 80-200kDa, identified as different members of CEA family. CEA is synthesized during development in the fetal gut and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. This MAb does not react with nonspecific cross-reacting antigen (NCA) and with human polymorphonuclear leucocytes. It shows no reaction with a variety of normal tissues and is suitable for staining of formalin/paraffin tissues. CEA is not found in benign glands, stroma, or malignant prostatic cells. Antibody to CEA is useful in detecting early foci of gastric carcinoma and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+). Anti-CEA positivity is seen in adenocarcinomas from the lung, colon, stomach, esophagus, pancreas, gallbadder, urachus, salivary gland, ovary, and endocervix. |
|||
Carcinoembryonic Antigen(CEA) Mouse Monoclonal Antibody |
|||
| 38016-100ul | SAB | 100ul | EUR 302.4 |
Carcinoembryonic Antigen(CEA) Mouse Monoclonal Antibody |
|||
| 38016-50ul | SAB | 50ul | EUR 224.4 |
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse) |
|||
| 4-PAA150Mu01 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA) |
|||
ELISA kit for Human CEA (Carcinoembryonic Antigen) |
|||
| E-EL-H0643 | Elabscience Biotech | 1 plate of 96 wells | EUR 640.8 |
|
Description: A sandwich ELISA kit for quantitative measurement of Human CEA (Carcinoembryonic Antigen) in samples from Serum, Plasma, Cell supernatant |
|||
ELISA kit for Rat CEA (Carcinoembryonic Antigen) |
|||
| E-EL-R0150 | Elabscience Biotech | 1 plate of 96 wells | EUR 640.8 |
|
Description: A sandwich ELISA kit for quantitative measurement of Rat CEA (Carcinoembryonic Antigen) in samples from Serum, Plasma, Cell supernatant |
|||
ELISA kit for Rat CEA (Carcinoembryonic Antigen) |
|||
| ELK1297 | ELK Biotech | 1 plate of 96 wells | EUR 446.4 |
|
Description: A sandwich ELISA kit for detection of Carcinoembryonic Antigen from Rat in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
ELISA kit for Human carcinoembryonic antigen,CEA |
|||
| EK0179 | SAB | 96 tests | EUR 794.4 |
|
Description: Enzyme-linked immunosorbent assay kit for quantification of Human carcinoembryonic antigen,CEA in samples from serum, plasma, tissue homogenates and other biological fluids. |
|||
Human Carcinoembryonic Antigen (CEA) OneStep ELISA Kit |
|||
| EK7031 | BosterBio | 96wells/kit, with removable strips. | EUR 573.6 |
ELISA kit for Human CEA (Carcinoembryonic Antigen) |
|||
| ELK1196 | ELK Biotech | 1 plate of 96 wells | EUR 446.4 |
|
Description: A sandwich ELISA kit for detection of Carcinoembryonic Antigen from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
CEA ELISA Kit| Rat Carcinoembryonic Antigen ELISA Kit |
|||
| EF017615 | Lifescience Market | 96 Tests | EUR 826.8 |
Human Carcinoembryonic Antigen (CEA) ELISA (4X96T) |
|||
| LF-EK0162 | Abfrontier | 4Ćā96T | EUR 2454 |
Human Carcinoembryonic Antigen (CEA) ELISA (10X96T) |
|||
| LF-EK0163 | Abfrontier | 10Ćā96T | EUR 5380.8 |
Human Carcinoembryonic Antigen (CEA) ELISA (20X96T) |
|||
| LF-EK0164 | Abfrontier | 20Ćā96T | EUR 9369.6 |
Human Carcinoembryonic Antigen (CEA) CLIA Kit |
|||
| abx196501-96tests | Abbexa | 96 tests | EUR 990 |
Rat Carcinoembryonic Antigen (CEA) CLIA Kit |
|||
| abx196777-96tests | Abbexa | 96 tests | EUR 990 |
Human Carcinoembryonic Antigen (CEA) CLIA Kit |
|||
| 20-abx491145 | Abbexa |
|
|
Rat Carcinoembryonic Antigen (CEA) CLIA Kit |
|||
| 20-abx491147 | Abbexa |
|
|
Carcinoembryonic Antigen/CEA Monoclonal Antibody |
|||
| EM1061-100ul | ELK Biotech | 100ul | EUR 334.8 |
|
Description: A Mouse Monoclonal antibody against Carcinoembryonic Antigen/CEA from Human/ Rat/ Mouse. This antibody is tested and validated for IHC |
|||
Carcinoembryonic Antigen/CEA Monoclonal Antibody |
|||
| EM1061-50ul | ELK Biotech | 50ul | EUR 248.4 |
|
Description: A Mouse Monoclonal antibody against Carcinoembryonic Antigen/CEA from Human/ Rat/ Mouse. This antibody is tested and validated for IHC |
|||
Human Carcinoembryonic Antigen (CEA) Protein |
|||
| 20-abx166414 | Abbexa |
|
|
Human Carcinoembryonic Antigen (CEA) Protein |
|||
| 20-abx065719 | Abbexa |
|
|
Human Carcinoembryonic Antigen (CEA) Protein |
|||
| 20-abx065721 | Abbexa |
|
|
Human Carcinoembryonic Antigen (CEA) Protein |
|||
| 20-abx065723 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody Pair |
|||
| 20-abx370130 | Abbexa |
|
|
Human Carcinoembryonic Antigen (CEA) Protein |
|||
| 20-abx651474 | Abbexa |
|
|
Rat Carcinoembryonic Antigen (CEA) Protein |
|||
| 20-abx652080 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (FITC) |
|||
| 20-abx270431 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (FITC) |
|||
| 20-abx270463 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (FITC) |
|||
| 20-abx270488 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (APC) |
|||
| 20-abx270663 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (APC) |
|||
| 20-abx270695 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (APC) |
|||
| 20-abx270720 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (PE) |
|||
| 20-abx270895 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (PE) |
|||
| 20-abx270927 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (PE) |
|||
| 20-abx270952 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (Biotin) |
|||
| 20-abx271833 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Antibody (Biotin) |
|||
| 20-abx272619 | Abbexa |
|
|
anti-Carcinoembryonic Antigen/CEA (10E1) |
|||
| LF-MA20354 | Abfrontier | 100 ug | EUR 424.8 |
|
Description: Mouse monoclonal to Carcinoembryonic Antigen (CEA) |
|||
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse), APC |
|||
| 4-PAA150Mu01-APC | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with APC. |
|||
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse), Biotinylated |
|||
| 4-PAA150Mu01-Biotin | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with Biotin. |
|||
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse), Cy3 |
|||
| 4-PAA150Mu01-Cy3 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with Cy3. |
|||
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse), FITC |
|||
| 4-PAA150Mu01-FITC | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with FITC. |
|||
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse), HRP |
|||
| 4-PAA150Mu01-HRP | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with HRP. |
|||
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse), PE |
|||
| 4-PAA150Mu01-PE | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with PE. |
|||
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human, Mouse) |
|||
| 4-PAA150Mu02 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Carcinoembryonic Antigen (CEA) |
|||
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human, Mouse) |
|||
| 4-PAA150Hu04 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Carcinoembryonic Antigen (CEA) |
|||
CLIA kit for Human CEA (Carcinoembryonic Antigen) |
|||
| E-CL-H0492 | Elabscience Biotech | 1 plate of 96 wells | EUR 700.8 |
|
Description: A sandwich CLIA kit for quantitative measurement of Human CEA (Carcinoembryonic Antigen) in samples from Serum, Plasma, Cell supernatant |
|||
CLIA kit for Rat CEA (Carcinoembryonic Antigen) |
|||
| E-CL-R0108 | Elabscience Biotech | 1 plate of 96 wells | EUR 700.8 |
|
Description: A sandwich CLIA kit for quantitative measurement of Rat CEA (Carcinoembryonic Antigen) in samples from Serum, Plasma, Cell supernatant |
|||
Mouse carcinoembryonic antign, CEA ELISA Kit |
|||
| CSB-E13925m-24T | Cusabio | 1 plate of 24 wells | EUR 198 |
|
Description: Quantitativesandwich ELISA kit for measuring Mouse carcinoembryonic antign, CEA in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
|||
Mouse carcinoembryonic antign, CEA ELISA Kit |
|||
| 1-CSB-E13925m | Cusabio |
|
|
|
Description: Quantitativesandwich ELISA kit for measuring Mouse carcinoembryonic antign, CEA in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
|||
Mouse CEA(Carcinoembryonic Antign) ELISA Kit |
|||
| EM0916 | FN Test | 96T | EUR 628.92 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 37.5pg/ml |
|||
Mouse carcinoembryonic antign(CEA)ELISA Kit ć |
|||
| GA-E0111MS-48T | GenAsia Biotech | 48T | EUR 403.2 |
Mouse carcinoembryonic antign(CEA)ELISA Kit ć |
|||
| GA-E0111MS-96T | GenAsia Biotech | 96T | EUR 640.8 |
Mouse carcinoembryonic antign,CEA ELISA Kit ć |
|||
| YLA0648MO-48T | Shanghai YL Biotech | 48T | EUR 465 |
Mouse carcinoembryonic antign,CEA ELISA Kit ć |
|||
| YLA0648MO-96T | Shanghai YL Biotech | 96T | EUR 600 |
Human Carcinoembryonic Antigen (CEA) Protein (Active) |
|||
| 20-abx655572 | Abbexa |
|
|
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Rat) |
|||
| 4-PAA150Hu01 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Rat Carcinoembryonic Antigen (CEA) |
|||
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human) |
|||
| 4-PAA150Hu02 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Carcinoembryonic Antigen (CEA) |
|||
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human) |
|||
| 4-PAA150Hu03 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Carcinoembryonic Antigen (CEA) |
|||
Carcinoembryonic Antigen (CEA) ELISA Kit (Human) : 96 Wells (OKBA00007) |
|||
| OKBA00007 | Aviva Systems Biology | 96 Wells | EUR 396 |
|
Description: Description of target: ;Species reactivity: Human;Application: ELISA;Assay info: ;Sensitivity: 1.0 ng/ml |
|||
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human, Mouse), HRP |
|||
| 4-PAA150Hu04-HRP | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with HRP. |
|||
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human, Mouse), PE |
|||
| 4-PAA150Hu04-PE | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with PE. |
|||
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Mouse), APC-Cy7 |
|||
| 4-PAA150Mu01-APC-Cy7 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with APC-Cy7. |
|||
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human, Mouse), APC |
|||
| 4-PAA150Mu02-APC | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with APC. |
|||
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human, Mouse), Biotinylated |
|||
| 4-PAA150Mu02-Biotin | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with Biotin. |
|||
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human, Mouse), Cy3 |
|||
| 4-PAA150Mu02-Cy3 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with Cy3. |
|||
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human, Mouse), FITC |
|||
| 4-PAA150Mu02-FITC | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human, Mouse Carcinoembryonic Antigen (CEA). This antibody is labeled with FITC. |
|||
Carcinoembryonic Antigen (CEA) Polyclonal Antibody (Human, Mouse), HRP |
|||
| 4-PAA150Mu02-HRP | Cloud-Clone |
|
|